AboutContactTerms & Privacy
© 2026 Coverager
All Rights Reserved

MediMabBio

Developer of cancer immunotherapies.

Headquarters
Seongnam, Kyonggi-do, South Korea
Founded
2017
Operating Status
Active
Ownership Type
Business Model
Links
Number of funding rounds 3
Number of investors 16
Total funding amount $20.79M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.